NPI: 1720611072 · BOSTON, MA 02114 · Durable Medical Equipment & Medical Supplies · NPI assigned 02/14/2020
Authorized official ANGELINE, GRACE controls 20+ related entities in our dataset. Read more
| Authorized Official | ANGELINE, GRACE (REG COMPLIANCE SPECIALIST IV) |
| Parent Organization | HANGER INC |
| NPI Enumeration Date | 02/14/2020 |
Other providers sharing the same authorized official: ANGELINE, GRACE
| Year | Claims | Total Paid |
|---|---|---|
| 2022 | 223 | $10K |
| 2023 | 65 | $5K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 64 | 53 | $8K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 79 | 62 | $4K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 23 | 15 | $2K |
| 80053 | Comprehensive metabolic panel | 30 | 28 | $260.68 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 31 | 29 | $198.65 |
| 86803 | 16 | 15 | $188.85 | |
| 83735 | 14 | 13 | $76.83 | |
| 84100 | 15 | 14 | $58.52 | |
| 86592 | 16 | 15 | $56.55 |